Beijing Bohui Innovation Biotechnology Group Second Quarter 2024 Earnings: EPS: CN¥0.01 (vs CN¥0.001 in 2Q 2023)

Simply Wall St · 08/31 00:25

Beijing Bohui Innovation Biotechnology Group (SZSE:300318) Second Quarter 2024 Results

Key Financial Results

  • Revenue: CN¥224.8m (down 18% from 2Q 2023).
  • Net income: CN¥7.77m (up by CN¥7.02m from 2Q 2023).
  • Profit margin: 3.5% (up from 0.3% in 2Q 2023). The increase in margin was driven by lower expenses.
  • EPS: CN¥0.01 (up from CN¥0.001 in 2Q 2023).
earnings-and-revenue-history
SZSE:300318 Earnings and Revenue History August 31st 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Beijing Bohui Innovation Biotechnology Group shares are up 5.2% from a week ago.

Risk Analysis

Before we wrap up, we've discovered 2 warning signs for Beijing Bohui Innovation Biotechnology Group that you should be aware of.